首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Progressive Multifocal Leukoencephalopathy Associated with Hematopoietic Stem Cell Transplant (HSCT) Has Better Prognosis Than PML Associated with Monoclonal Antibodies or Chemotherapy in Hematological Malignancies : Analysis of a Case Series

【24h】

Progressive Multifocal Leukoencephalopathy Associated with Hematopoietic Stem Cell Transplant (HSCT) Has Better Prognosis Than PML Associated with Monoclonal Antibodies or Chemotherapy in Hematological Malignancies : Analysis of a Case Series

机译：在血液系统恶性肿瘤中，与造血干细胞移植（HSCT）相关的进行性多灶性白质脑病的预后要优于与单克隆抗体或化学疗法相关的PML的预后。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共2页
作者
Raajasekar Arun Kumar A.; Ayyapan Sabarish; Khan Hina; Mantzaris Ioannis; Janakiram Murali;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Progressive Multifocal Leukoencephalopathy Associated with Hematopoietic Stem Cell Transplant (HSCT) Has Better Prognosis Than PML Associated with Monoclonal Antibodies or Chemotherapy in Hematological Malignancies : Analysis of a Case Series [J] . Raajasekar Arun Kumar A., Ayyapan Sabarish, Khan Hina, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：在血液系统恶性肿瘤中，与造血干细胞移植（HSCT）相关的进行性多灶性白质脑病的预后要优于与单克隆抗体或化学疗法相关的PML的预后。
2. Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT [J] . Mohty Mohamad, Labopin Myriam, Velardi Andrea, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：同种异体遗传修饰的T细胞（HSV-TK）作为高风险血液恶性肿瘤的成年患者寄生造血干细胞移植（HAPLO-HSCT）中的辅助治疗：EBMT急性白血病工作组的对分析
3. Analysis of efficacy and prognosis of allogeneic hematopoietic stem cell transplantation from different donors in treatment of hematologic malignancies [J] . 余正平中国医学文摘：内科学分册（英文版） . 2013,第001期

机译：不同供体同种异体造血干细胞移植治疗血液系统恶性肿瘤的疗效和预后分析
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. The burden of parainfluenza virus infection in patients with hematological malignancy and hematopoietic stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of infection control. [D] . Hanmod, Santosh S. 2009

机译：在没有积极免疫和批准治疗的情况下，血液恶性肿瘤和造血干细胞移植（HSCT）患者的副流感病毒感染负担：感染控制的作用。
6. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT) [O] . Anna S. Świerzko, Mateusz Michalski, Anna Sokołowska, 2018

机译：补充激活收集素和相关丝氨酸蛋白酶在血液恶性肿瘤患者中的作用接受高剂量化疗以及自体造血干细胞移植（Auto-HSCT）
7. Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy [O] . College of Medicine, Division of Hematology/Oncology, University of Florida, Gainesville, FL ( host institution ), Riwes, Mary Mansour ( UF author ), Leather, Helen ( UF author ), 2013

机译：进行造血干细胞移植（HSCT）或接受化学疗法的血液系统恶性肿瘤患者中，甘露糖结合凝集素（MBL）水平与侵袭性真菌病（IFD）的关联

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号